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ABSTRACT
Background: Enlargement in the extraoral region with the absence of abnormal 
dental and periodontal structures are sometimes seen in dental practice, sometimes 
followed by xerostomia. Enlargement of the acute nonsuppurative salivary glands 
has been associated with several types of viruses. The purpose of this paper is to 
review salivary gland diseases associated with non-HIV and HIV viral infections. 
Discussion: Non-HIV viruses which were detected in the salivary glands including 
Paramyxovirus, cytomegalovirus (CMV), Hepatitis C virus (HCV), human papilloma 
viruses (HPV), Epstein-Barr virus (EBV), human herpes simplex virus (HHSV-8), 
and coxsackie virus. HIV-associated salivary gland disease typically presents with 
xerostomia and/or intraglandular lymph nodes, and diffuse infiltrative lymphocytosis 
syndrome (DILS). The most common viral infection conditions in salivary gland 
disorders are mumps and HIV. Enlargement and inflammation of the glandular 
structures will affects the control of salivary secretion by nerves. Parasympathetic 
nerves block conducted signals to the salivary glands, so the salivary flow is 
decreased.
Conclusion: There is association between viral infection and diseases of the 
salivary gland. By knowing sequelae viruses on the salivary gland, dentists are 
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INTRODUCTION
Saliva is a complex combination of fluids, 
electrolytes, enzymes, and macromolecules 
that together do several important functions: 
lubrication to help swallowing; producing am-
ylase enzymes to help digestion; taste mod-
ulation; protection against caries and patho-
gens.1–3 The salivary glands are the paired 
parotid, submandibular and lingual glands 
along with several hundred minor salivary 
glands, distributed through the upper aerodi-
gestive system.1,4,5 
Salivary gland disorders are often associ-
ated with viral infections.1,4,6–8 Enlargement of 
the acute nonsuppurative salivary glands has 
been associated with several types of virus-
es.4,7 Viruses that cause most gland enlarge-
ment are paramyxovirus, cytomegalovirus 
(CMV), hepatitis C virus (HCV), Human Pap-
illoma Virus (HPV), Epstein-Barr Virus (EBV), 
Human Herpes Virus 8 (HHV-8) and HIV. 4,9–15 
Other virus detected in Saliva are coxsackie vi-
rus, influenza, parainfluenza virus, echovirus, 
BK virus, Human T-lymphotropic virus (HTLV), 
human herpesvirus 6 (HHV-6), human herpes-
virus 7 (HHV-7), Kaposi sarcoma virus (KSHV), 
guinea pig CMV, mouse CMV (MCMV), mouse 
polyomavirus (PyV), encephalomyocarditis 
(EMC).6,9 Sometimes accompanied with xero-
stomia as the manifestation of viral infection. 
HIV-associated salivary gland disease typi-
cally presents with xerostomia and/or swelling 
of the major salivary glands. It encompasses 
multitude of conditions like lymphoepithelial le-
sions, cysts involving the salivary gland tissue 
and/or intraglandular lymph nodes, Sjogren’s 
syndrome-like conditions, diffuse infiltrative 
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lymphocytis syndrome (DILS), and other re-
ported lesions of the major salivary glands.16–19 
About 5% of HIV patients exhibit HIV-Associat-
ed salivary gland disease (HIV-SGD).8 
In this literature study, we dividing viral in-
fections salivary gland disease due to non-HIV 
and HIV. The purpose of this paper is to review 
salivary gland diseases associated with non-
HIV and HIV viral infections.
LITERATURE REVIEW
Viruses in Latin means venom or poison. 
Viruses are ultramicroscopic organisms which 
breed in living cells, inert metabolically, capa-
ble of infecting other organisms. The size of 
viruses ranges from 10 millimeters or less to 
more than 200 millimicrons. The virus consists 
of a DNA or RNA nucleus, surrounded by a 
capsid made of protein or an outer envelope 
made of glycoproteins and lipids derived from 
the host cell membranes.8,9,11,13,14  
Classification of diseases caused by vi-
ruses is difficult because of the virus size and 
metabolic system that have not been fully un-
derstood. International Committee on Nomen-
clature of Viruses of the International Associa-
tion of Microbiological Societies has classified 
them into groups according to the type of nu-
cleic acid, the size, shape, and substructure of 
the particle.8 
Paramyxovirus, cytomegalovirus (CMV), 
hepatitis C virus (HCV), Human Papilloma Vi-
rus (HPV), Epstein-Barr Virus (EBV), Human 
Herpes Virus 8 (HHV-8) and HIV are several 
viruses that causing salivary gland enlarge-
ment and sometimes xerostomia. 4,9–15 In this 
paper we will review those viruses, divided into 
non-HIV viral infections of the salivary gland 
and HIV associated salivary gland disease.
Non-HIV Viral Infection of The Salivary 
Gland 
Paramyxovirus/Mumps
Mumps is an acute, self-limiting, contagious 
viral infection characterized chiefly by unilateral 
or bilateral swelling of the parotid, although all 
salivary glands may be involved.8,9 85% of cas-
es occur in children younger than 15 years.1,9 
Human are the only natural host. Infection 
occurs following exposure through the upper 
respiratory tract by droplet, aerosol, direct con-
tact, or fomites. The prodromal symptoms are 
fever, malaise, and headache. Approximately 
24 hours later, glandular swelling, tenderness, 
and associated earache can occurs. Resolu-
tion of symptoms generally occur in 10 days.9  
Complications including orchitis, acute pan-
creatitis, meningoencephalitis, deafness, and 
mastoiditis.8,9
Mumps should be differentiated from other 
parotid swelling which were caused by influen-
za, parainfluenza 1 and 3, coxsackie, HIV, cy-
tomegalovirus, Sjögren’s syndrome, pleomor-
phic adenoma, etc.8 Diagnosis is confirmed 
through viral serology test. The treatment are 
supportive measures, including hydration, rest, 
oral hygiene instruction and pain control or an-
tipyretic.4,9 According to Centers for Disease 
Control and Prevention (2014), vaccination is 
88% effective in preventing mumps and has 
reduced the incidence by 99%.1 Currently, the 
CDC recommends mumps patients should 
avoid contact with others from the time of di-
agnosis until at least five days after the onset 
of parotitis by staying at home from work or 
school and in a separate room if possible.4,23
Cytomegalovirus (CMV) 
CMV (HHV-5) is a member of the Herpes-
viridae family. As the characteristic of other 
members of Herpesviridae, CMV can become 
latent after initial exposure and infection and 
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may become reactivated when favorable con-
ditions are present. The majority of CMV infec-
tions are asymptomatic, especially in healthy 
individuals; however, in immunocompromised 
patients and neonates, the infection can be 
life-threatening. In the young adult, acute CMV 
infection presents with fever, malaise, myalgia; 
pharyngitis and lymphadenopathy. Oral and 
maxillofacial manifestations of CMV in immu-
nosuppressed patients typically present as 
persistent oral ulcerations and major salivary 
gland infections, with or without concomitant 
alterations in salivary flow.4,24 CMV infection 
has been investigated as one of the causative 
agents in Sjogren’s syndrome with a molecular 
mimicry mechanism of pathogenesis. Viruses 
affect exocrine tissue primarily through plas-
macytoid dendritic cells (pDCs) and Toll-like-re-
ceptors (TLRs).25 Transmission occurs through 
blood transfusion, allograft transplants, sexual 
contact, fomites, urine, saliva, and respiratory 
secretions.4,24,26 In HIV-positive patients, the 
degree of CMV-induced sialadenitis and/or xe-
rostomia was found to be proportional to the vi-
ral load and inversely proportional to the CD4+ 
cell count.
Several diagnostic modalities for CMV are 
available including serology, qualitative and 
quantitative PCR, as well as histopathology. 
The choice of test is based on the status of 
the immune system of the patient. Treatment 
in those with symptomatic infection are sup-
portive and symptomatic care (i.e., analgesics, 
rest, hydration). Immunocompromised patients 
require aggressive antiviral therapy that may 
be in the form of ganciclovir, valganciclovir, 
foscarnet, or cidofovir.4,24
Hepatitis C Virus (HCV)
Hepatitis C virus (HCV) is one of the ma-
jor causes of chronic liver disease worldwide, 
as the global estimated prevalence of HCV 
is 2.2% with 40-75% of patients with chronic 
HCV infection exhibit at least one clinical ex-
trahepatic manifestation (EHM).15,20 HCV infec-
tion has many extrahepatic manifestations, in-
cluding sialadenitis and chronic major salivary 
gland enlargement and complaints of xerosto-
mia and sicca syndrome (Sjogren-like sialade-
nitis) are common.4,20,27 
The diagnosis of HCV infection is estab-
lished by the serologic detection of anti-HCV 
antibodies by ELISA and HCV DNA by PCR. 
Treatment of patients with acute HCV infection 
receives weekly PegIFN-alpha or standard in-
terferon. Hepatitis-associated sialadenitis and 
xerostomia are treated symptomatically.4
Human Papilloma Virus (HPV)
Human Papilloma Virus (HPV) has been 
demonstrated to be the trigger of neoplastic 
diseases of the head and neck.10,28 Moreover, 
the medical literature provides only little evi-
dence about the role of HPV in salivary gland 
tumors.13,29 HPV-16 and HPV-18 are the most 
commonly detected high-risk types.28,30,31  Due 
to the growing rates of salivary gland tumors 
and positivity of HPV types 16 and 18, some 
studies hypothesized that use of the two avail-
able HPV vaccines for cervix carcinoma may 
cause a reduction of salivary gland cancer.29–32
Table 1. Differences between sialadenitis in Sjogren’s syndrome and hepatitis C virus. Modified
from Carrozzo M et al.15
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Epstein-Barr Virus (EBV)
Same like HPV, studies in head and neck 
neoplasms revealed that Epstein-Barr virus 
(EBV) have implicated as aetiological factors.11 
EBV is an enveloped DNA herpesvirus that is 
transmitted by saliva and is shed even in ap-
parently healthy subjects. EBV not only found 
in malignant neoplasms like salivary gland 
lymphoma, but also in benign lesions such as 
lymphoepithelial cyst and Warthin’s tumor.11,33 
Some studies have been founded that EBV is 
the co-factor in the development of Sjogren’s 
syndrome.25
Human Herpes Virus 8 (HHV-8)
Human Herpes Virus 8 (HHV-8), a gam-
ma-2 herpes virus (rhadinovirus) which nat-
urally infects only humans, is the cause of 
several neoplastic disorders among immuno-
compromised individuals, especially Kaposi’s 
sarcoma, although salivary gland Kaposi’s sar-
coma is rare. Dalpa et al, 2007 investigate that 
HHV-8 infection could play a role in a subset of 
adenoid salivary neoplasms.9,12
Coxsackie Virus
Coxsackie virus is an RNA virus potential 
localized, presence and replicates in exocrine 
glands of patients with Sjogren’s syndrome. 
Triantafyllopou et al, 2004, reported for the first 
time an association of a coxsackievirus infec-
tion with primary Sjogren’s syndrome. Cox-
sackie virus replication takes place in the sub-
mucosal lymph tissue and then disseminates 
to the reticuloendothelial system. Further dis-
semination targeting the organs occurs follow-
ing a second viremia. RNA from two strains, 
CVB4 and CVA13,has been identified in minor 
salivary gland samples from pSS, therefore im-
plicating Coxsackie virus of a potential environ-
mental trigger for Sjogren’s syndrome.25,34–36
HIV-Associated Salivary Gland Disease 
(HIV-SGD)
HIV-SGD is define as AIDS in pediatric 
HIV infection and has increased in the adult 
HIV population.6,16 Typically, HIV-SGD pres-
ents a unilateral or bilateral diffuse soft swell-
ing resulting in facial disfigurement, and may 
be associated with pain.6 As HIV progresses, 
salivary glands are infiltrated with CD8 lym-
phocytes leading to diffuse infiltrative lympho-
cytosis syndrome, resulting in salivary gland 
enlargement. 
Another manifestation of HIV-associated 
salivary gland disease is that qualitative and 
quantitative xerostomia (reduced salivary se-
cretion) may occur. The causes of xerostomia 
including drugs (antiretrovirals, antifungals, 
chemotherapeutics, antihistaminics, mood-al-
tering drugs, multivitamins), oral diseases 
(candidiasis) or as a part of the progression 
of the HIV disease.8,17 There are evidence 
that HIV-SGD increases with HAART therapy.6 
The dentist should identify xerostomia early 
and provide nutritional counseling as well as 
preventive treatment with fluorides and other 
agents including chlorhexidine/benzydamine 
hydrochloride and triclosan/fluoride mouth 
rinse.18 Management of HIV associated xero-
stomia involving antiretroviral therapy, oral hy-
giene instruction, and sialagogues.1
Diffuse Infiltrative Lymphocytic Syndrome 
(DILS)
DILS is characterized by salivary and lac-
rimal glandular swelling and sicca symptoms 
of various degrees of intensity, accompanied 
by a proliferation of  CD8+ lymphocytes and 
lymphocytic infiltration of the various organ 
including parotid glands, lacrimal glands, 
kidneys, muscles, nerves, lungs, and lymph 
nodes in association with HIV infection.6,16 
DILS mimicking Sjogren’s syndrome in terms 
of sicca symptoms, salivary glandular enlarge-
ment, histology, and predisposition to develop 
non-Hodgkin’s lymphoma.6 
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DISCUSSION
The viral organism that first comes to mind 
when considering non-HIV viral infections of 
the salivary glands is the mumps virus. The 
mumps virus is a paramyxovirus from influen-
za and Newcastle groups. Like measles, it is 
a single-stranded RNA virus. Humans are the 
only natural host.9 Some systemic complica-
tions may be serious, including meningitis, en-
cephalitis, hepatitis, carditis, orchitis and hear-
ing loss, therefore the patient must be isolated 
for several days.4,7 Vaccine has been reported 
eradicated outbreaks.9 The treatment are sup-
portive care.
Several viruses, including DNA, RNA, and 
retroviruses have been considered as the 
important co-factors in the development of 
Sjogren’s syndrome. The two DNA viruses that 
have been studied in association with Sjogren’s 
syndrome are cytomegalovirus (CMV) and Ep-
stein-Barr virus (EBV).25,36,37 Overall the data 
regarding CMV and EBV as causative agents 
for Sjogren’s syndrome are contradictory, and, 
because Sjogren’s syndrome does not occur 
in most cases of viral infection in vivo. The link 
between reactivation and autoimmunity induc-
tion remains to be established. Epstein Barr 
virus (EBV), human papillomavirus (HPV), 
human herpesvirus-8 (HHV-8) have an asso-
ciation with tumorigenesis and lead into some 
neoplasm in salivary gland.11–13,33 Two RNA vi-
ruses have been detected within the salivary 
glands of Sjogren’s syndrome patients i.e. 
hepatitis C virus (HCV) and Coxsackie virus, 
both of which require more investigation be-
fore they are classified as being the etiologi-
cal agent of Sjogren’s syndrome.20,25,34–36 The 
diagnosis can be confirmed by viral serology 
examination.
The epidemiology of HIV-SGD strongly 
suggests the involvement of a viral opportun-
ist in its pathogenesis.16 The conditions that 
associated with HIV including xerostomia, 
DILS, lymphoepithelial lesions of the parotid 
gland, CMV infection, hepatitis C virus infec-
tion, mumps, sialodenosis, parotid cysts.4,8,16,17 
Another significant increase in prevalence of 
HIV-SGD was reported in patients under high-
ly active antiretroviral therapy (HAART) in the 
AIDS population.19 The relationship between 
HAART and HIV-SGD may be due to the pa-
tients in early stages of the disease who re-
main in the initial phase of HAART therapy and 
still have relatively high viral loads and are thus 
subject to an increased risk of developing HIV-
SGD.16,19 
The most common viral infection conditions 
in salivary gland disorders are mumps or HIV 
with swelling as the clinical presentation, often 
bilateral; may be tender, followed by xerosto-
mia. Xerostomia is defined as the subjective 
sensation of oral dryness that may or may not 
be associated with a reduction in salivary out-
Table 2. Comparison of Salivary Gland Disorders: HIV-associated Salivary Gland Disease vs Sjogren’s 
Syndrome6
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put. Xerostomia may be transient, prolonged or 
permanent depending upon the duration of the 
condition. Acute viral infection is the temporary 
cause of xerostomia, meanwhile, Sjogren’s 
syndrome and tumor that precipitated by vi-
ral infection, are the permanent cause.37–39 
Salivary gland cells are intimately associated 
with the autonomic nervous system. Parasym-
pathetic and sympathetic nerves run together 
with Schwann cells to the target cells in sali-
vary glands. Parasympathetic stimulates sali-
va, and sympathetic is inhibiting saliva produc-
tion. Parasympathetic and sympathetic nerves 
are in contact with many types of cell in sali-
vary glands, including acinar, ductal and myo-
epithelial cells as well as blood vessels.40,41 
Enlargement and inflammation of the glandu-
lar structures will affect the control of salivary 
secretion by nerves. Parasympathetic nerves 
block conducted signals to the salivary glands, 
therefore the salivary flow is decreased.
CONCLUSION 
There is association between viral infection 
and diseases of the salivary gland. In general, 
viral infection of the salivary gland may result 
in swelling and/or reduced saliva production. 
By knowing sequelae viruses on the salivary 
gland, dentists are expected to understand the 
clinical and therapeutic conditions given to pa-
tients.
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